Regencell Bioscience Holdings Ltd. (RGC)
Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
CNSX $
19. 69
-0.76
-3.7164%
$
10.96B Market Cap
- P/E Ratio
- Div Yield
89,999 Volume
0 Eps
$ 20.45
Previous Close 
Want to track RGC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regencell Bioscience Holdings Ltd. (RGC) Statistics
Valuation metrics
Market Cap 10.96B
Enterprise value 9.88B
Trailing P/E (ttm) -1,402.39
Forward P/E -
PEG ratio -15.61
Price/Sales (ttm) -
Price/Book (mrq) 8,106.42
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1,405.77
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 101.28K
Average volume (90 days) 137.61K
Price summary
52-Week low 9.39
52-Week high 83.6
Beta -
50-Day moving average 27.79
200-Day moving average 25.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 38:1
Last split Date 16 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.34%
Return on equity -2.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.32
Current ratio (mrq) 1.42%
Book value per share (mrq) 0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
